Zai Lab Closes USD 249.93 Million Private Placement of ADSs

By Public Technologies
  • Zai Lab closed a private placement of 11,340,000 American depositary shares on October 27, 2026, raising approximately USD 249.93 million gross.
  • The USD 22.04 ADS price represents a 7.13% discount to the preceding five-day average ordinary share closing price.
  • Net proceeds totaled approximately USD 241.17 million, primarily earmarked for continued global development of zocilurtatug pelitecan, its DLL3-targeting antibody-drug conjugate.
  • Placement investors hold 113,400,000 ordinary shares, representing 9.06% of total issued ordinary shares upon completion.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Zai Lab Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261028-12386773), on October 28, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk